Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Gelenberg, A. J.
	Articles by Growdon, J. H.
	Search for Related Content



	PubMed Citation
	Articles by Gelenberg, A. J.
	Articles by Growdon, J. H.

Am J Psychiatry 1979; 136:772-776
Copyright © 1979 by American Psychiatric Association

REGULAR ARTICLES

Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study

AJ Gelenberg, JC Doller-Wojcik and JH Growdon

Tardive dyskinesia is thought to reflect increased dopaminergic activity of the central nervous system. To compensate for this by increasing CNS cholinergic tone, the authors administered oral choline and its natural dietary source, lecithin, to 5 men with mild to severe tardive dyskinesia in a nonblind trial. Both choline and lecithin increased serum choline levels and improved abnormal movements in all patients. Lecithin had fewer adverse effects.

This article has been cited by other articles:

R. Bartus, R. Dean 3rd, B Beer, and A. Lippa
The cholinergic hypothesis of geriatric memory dysfunction
Science, July 30, 1982; 217(4558): 408 - 414.
[Abstract] [PDF]

Get information about faster international access.